Curaleaf Celebrates President Trump's Landmark Rescheduling of Cannabis Under Controlled Substances Act

Curaleaf Celebrates President Trump's Landmark Rescheduling of Cannabis Under Controlled Substances Act

Trump Administration's Rescheduling Opens New Avenues for Research, Medical Advancement, and Investment

STAMFORD, Conn., Dec. 18, 2025 /PRNewswire/ -- Curaleaf Holdings, Inc. (TSX: CURA) (OTCQX: CURLF) ("Curaleaf" or the "Company"), a leading international provider of consumer cannabis products, today applauds the Trump Administration's action to implement the most impactful federal cannabis reform of the past fifty years by rescheduling cannabis as a Schedule III substance under the Controlled Substances Act of 1970.

"Curaleaf thanks President Trump for acting on his commitment to move forward with cannabis reclassification and we express our deep gratitude to him for this bold move," said Boris Jordan, Chairman and CEO of Curaleaf. "Moving the plant from Schedule I to Schedule III acknowledges what has been known for thousands of years, that the cannabis plant has medicinal properties. This policy shift by the United States government sets a precedent for how cannabis should be viewed globally and we eagerly await Attorney General Pam Bondi's prompt execution of President Trump's order."

Rescheduling cannabis to Schedule III is a meaningful step toward destigmatizing the plant by opening avenues to federally funded clinical research, supporting veterans, expanding patient access, and more. It also eliminates onerous tax penalties and creates opportunities for expanded investment into state programs that will create jobs and tax revenue for local communities.

"Under President Trump's leadership," Jordan continued, "this historic action will help bring logic to federal cannabis policy, ensuring the law reflects both scientific understanding and widespread public support. Momentum has been building across party lines for decades, and now is the time for meaningful, lasting reform."

The reclassification of cannabis aligns with nearly nine-in-ten U.S. adults who support legalization for medical use, recreational use, or both. Curaleaf remains committed to the destigmatization and decriminalization of cannabis through community-based initiatives. For more information about Curaleaf's community-based initiatives, retail locations or product offerings, please visit https://curaleaf.com.

About Curaleaf Holdings

Curaleaf Holdings, Inc. (TSX: CURA) (OTCQX: CURLF) ("Curaleaf") is a leading international provider of consumer products in cannabis with a mission to enhance lives by cultivating, sharing and celebrating the power of the plant. As a high-growth cannabis company known for quality, expertise and reliability, the Company and its brands, including Curaleaf, Select, Grassroots, Find, Anthem, and The Hemp Company provide industry-leading service, product selection and accessibility across the medical and adult use markets. Curaleaf International is powered by a strong presence in all stages of the supply chain. Its distribution network throughout Europe, Canada and Australasia brings together pioneering science and research with cutting-edge cultivation, extraction and production. Curaleaf is listed on the Toronto Stock Exchange under the symbol CURA and trades on the OTCQX market under the symbol CURLF. For more information, please visit https://ir.curaleaf.com.

Forward Looking Statements
This media advisory contains forward-looking statements and forward-looking information within the meaning of applicable securities laws. These statements relate to future events or future performance. All statements other than statements of historical fact may be forward–looking statements or information. Generally, forward-looking statements and information may be identified by the use of forward-looking terminology such as "plans", "expects" or "proposed", "is expected", "intends", "anticipates", or "believes", or variations of such words and phrases, or by the use of words or phrases which state that certain actions, events or results may, could, would, or might occur or be achieved. More particularly and without limitation, this news release contains forward-looking statements and information concerning the federal rescheduling of cannabis. Such forward-looking statements and information reflect management's current beliefs and are based on assumptions made by and information currently available to the company with respect to the matter described in this new release. Forward-looking statements involve risks and uncertainties, which are based on current expectations as of the date of this release and subject to known and unknown risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements. Additional information about these assumptions and uncertainties is contained under "Risk Factors and Uncertainties" in the Company's latest annual information form filed on March 3, 2025, which is available under the Company's SEDAR profile at http://www.sedar.com, and in other filings that the Company has made and may make with applicable securities authorities in the future. Forward-looking statements contained herein are made only as to the date of this press release and we undertake no obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise, except as required by law. We caution investors not to place considerable reliance on the forward-looking statements contained in this press release. The Toronto Stock Exchange has not reviewed, approved or disapproved the content of this news release.

Investor Contact:
Curaleaf Holdings, Inc.
Camilo Lyon, Chief Investment Officer
IR@curaleaf.com

Media Contact:
MATTIO Communications
MattioCuraleaf@Mattio.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/curaleaf-celebrates-president-trumps-landmark-rescheduling-of-cannabis-under-controlled-substances-act-302646326.html

SOURCE Curaleaf Holdings, Inc.